
New paper alert 🚨and my first co-author under @wsuthinklab 🤩 Endocannabinoid dysregulation & PTSD in urban adolescents link.springer.com/article/10…

PhD in PharmTox. Critical scientist who sometimes studies psychedelics. 🧬🧠 Postdoc at @wsuthinklab. Communicator via @psychedbrainsci. 🤡 Queer, She/Her.

New paper alert 🚨and my first co-author under @wsuthinklab 🤩 Endocannabinoid dysregulation & PTSD in urban adolescents link.springer.com/article/10…

Thank you for asking. You seem serious. Yes, patient access is important. This isn't about access. Mindbloom is introducing people to minimally supervised injectable ketamine. This is a public health experiment. A few comments:
What's the basis for your concern? Mindbloom's outcomes were published in 2 peer-reviewed studies with 11,441 clients showing our at-home ketamine therapy with sublingual tablets is effective and safe. But sublingual doesn't work for everyone, and subcutaneous injection gives patients and providers more options to find the right treatment. It removes certain risks of sublingual, and allows clinicians to prescribe fewer mgs of ketamine. Launching subcutaneous administration wasn't a rash decision - we piloted it for a year with supervision from a medical review board to confirm effectiveness and safety. We've shared our data with independent researchers for publication, and you can read our white paper here mindbloom-guides.s3.us-east-… Second Mindbloom study: sciencedirect.com/science/ar…

SSDP's Drug Education Committee is hard at work revamping our Just Say Know curriculum to provide comprehensive, unbiased, and evidence-based drug education for students and youth across the country. We need your help to make it happen here: buff.ly/4iEWEz3

What are your favorite or least favorite psychedelic moments this year? Most standout events/papers/talks? Let us know!!
Year in review is coming up… What were some of the most standout moments in the psychedelic space this year? Let us know below and stay tuned for a short recap of 2024 special episode 😘 #psychedelics #yearinreview #2024

how it feels sending work emails in december

Like they do not have abuse potential, they don’t even act through the same mechanisms as other drugs that have higher abuse potential, they’re pharmacokinetics do not share hallmarks with commonly used drugs ITS A FEATURE NOT A BUG!!!

I would love to know who decided that bc psychedelics don’t produce self-admin that assay isn’t valid to measure their abuse liability When IN FACT the “limited” or “sporadic” or “unreliable” self-admin of psychs is consistent with the use patterns of humans smh

How do we live better knowing we will someday die? 💀 Alex Sielaff, PhD, dives into existential psychology and explores how psychs, breathwork, and other out there experiences might (or might not) help us live more meaningful lives. 🌌 open.spotify.com/episode/2W0…

My latest, via @Filtermag_org! Honored to be able to expand my coverage back to my home state — I grew up less than an hour from Louisa County and hope to interview Dawn Morris in person before she’s sentenced in February.
“No one should be facing dying in prison for a smaller-scale operation than what many multi-state corporations are doing on a daily basis.” Outrage at a potential sentence of 160 years in a state where cannabis possession is legal. @JackGorsline reports: filtermag.org/virginia-canna…

When writing a paper or doing an analysis would you say it’s important to include data published in the last 5 years leading up to your publication?

Animal researchers - Is drug discrimination still considered the golden standard for assessing abuse liability in 2024?

The never-ending millennial struggle to refrain from ending a sentence in an email with “lol” is EXHAUSTING.

New publication from CPCR Faculty Albert Garcia-Romeu, Sandeep Nayak (@sdpnayak), Nathan Sepeda (@n_sepeda), and colleagues! sciencedirect.com/science/ar…

Structural insights into tryptamine psychedelics: The role of hydroxyl indole ring site in 5-HT2A receptor activati… pubmed.ncbi.nlm.nih.gov/3954…

Our final episode in the #psychedelic circuitry series!! And maybe the year?? This episode dives into threat, amygdala, PVN + how psychedelics alter these responses in male and females animal models! Featuring the great @devin_effinger! psychedelicbrainscience.com/…

Best of luck to all submitting grad school apps this cycle! It’s been a privilege to support some amazing folks ☀️ PLEASE remember that your worth is NOT dependent on the outcome — it’s truly so subjective & there will ALWAYS be more chances. You deserve rest & celebration! 🙌🏾🫶🏾